Wealthfront Advisers
IBB icon

Wealthfront Advisers’s iShares Biotechnology ETF IBB Stock Holding History

Wealthfront Advisers’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.81M Buy
14,753
+1,518
+11% +$261K 0.01% 558
2026
Q1 		$2.23M Buy
13,235
+340
+3% +$58.1K ﹤0.01% 585
2025
Q4 		$2.18M Buy
12,895
+1,684
+15% +$274K ﹤0.01% 579
2025
Q3 		$1.62M Buy
11,211
+951
+9% +$130K ﹤0.01% 619
2025
Q2 		$1.3M Buy
10,260
+2,515
+32% +$309K ﹤0.01% 639
2025
Q1 		$991K Sell
7,745
-3,921
-34% -$532K ﹤0.01% 660
2024
Q4 		$1.54M Buy
11,666
+1,933
+20% +$272K ﹤0.01% 580
2024
Q3 		$1.42M Buy
9,733
+260
+3% +$37.6K ﹤0.01% 579
2024
Q2 		$1.3M Sell
9,473
-1,236
-12% -$165K ﹤0.01% 573
2024
Q1 		$1.47M Buy
10,709
+1,933
+22% +$264K 0.01% 541
2023
Q4 		$1.19M Buy
8,776
+3,611
+70% +$441K ﹤0.01% 565
2023
Q3 		$632K Sell
5,165
-1,816
-26% -$231K ﹤0.01% 648
2023
Q2 		$886K Buy
6,981
+1,241
+22% +$161K ﹤0.01% 579
2023
Q1 		$741K Buy
5,740
+532
+10% +$69.6K ﹤0.01% 581
2022
Q4 		$684K Buy
5,208
+370
+8% +$47.8K ﹤0.01% 576
2022
Q3 		$566K Buy
4,838
+630
+15% +$78.2K ﹤0.01% 571
2022
Q2 		$495K Buy
4,208
+162
+4% +$19.2K ﹤0.01% 591
2022
Q1 		$527K Buy
4,046
+945
+30% +$123K ﹤0.01% 621
2021
Q4 		$473K Buy
+3,101
New +$480K ﹤0.01% 605

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wealthfront Advisers's IBB Position: Q2 2026 in Review

Wealthfront Advisers increased its iShares Biotechnology ETF (IBB) stake by 11% in Q2 2026, buying an estimated $261K and bringing the position to 14,753 shares worth $2.81M. The position accounts for 0.01% of the portfolio, ranked #558.

Wealthfront Advisers first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Wealthfront Advisers held 14,753 shares of iShares Biotechnology ETF worth $2.81M as of Q2 2026.
  • Wealthfront Advisers bought 1,518 iShares Biotechnology ETF shares in Q2 2026, an estimated $261K.
  • iShares Biotechnology ETF made up 0.01% of Wealthfront Advisers's portfolio in Q2 2026, its #558 holding.
  • Wealthfront Advisers first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Wealthfront Advisers's 13F filing for Q2 2026, filed 7 Aug 2026.